Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale.

Major Facilitator Superfamily Membrane transporters Molecular Dynamics Protein-lipid interactions Structural Pharmacology

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 17 01 2023
revised: 23 01 2023
accepted: 27 01 2023
pubmed: 6 2 2023
medline: 3 3 2023
entrez: 5 2 2023
Statut: ppublish

Résumé

The Organic Anion Transporter 1 is a membrane transporter known for its central role in drug elimination by the kidney. hOAT1 is an antiporter translocating substrate in exchange for a-ketoglutarate. The understanding of hOAT1 structure and function remains limited due to the absence of resolved structure of hOAT1. Benefiting from conserved structural and functional patterns shared with other Major Facilitator Superfamily transporters, the present study intended to investigate fragments of hOAT1 transport function and modulation of its activity in order to make a step forward the understanding of its transport cycle. μs-long molecular dynamics simulation of hOAT1 were carried out suggesting two plausible binding sites for a typical substrate, adefovir, in line with experimental observations. The well-known B-like motif binding site was observed in line with previous studies. However, we here propose a new inner binding cavity which is expected to be involved in substrate translocation event. Binding modes of hOAT1 co-substrate α-ketoglutarate were also investigated suggesting that it may bind to highly conserved intracellular motifs. We here hypothesise that α-ketoglutarate may disrupt the pseudo-symmetrical intracellular charge-relay system which in turn may participate to the destabilisation of OF conformation. Investigations regarding allosteric communications along hOAT1 also suggest that substrate binding event might modulate the dynamics of intracellular charge relay system, assisted by surrounding lipids as active partners. We here proposed a structural rationalisation of transport impairments observed for two single nucleotide polymorphisms, p.Arg50His and p.Arg454Gln suggesting that the present model may be used to transport dysfunctions arising from hOAT1 mutations.

Identifiants

pubmed: 36739760
pii: S0753-3322(23)00130-0
doi: 10.1016/j.biopha.2023.114342
pii:
doi:

Substances chimiques

Ketoglutaric Acids 0
Organic Anion Transport Protein 1 0
Membrane Transport Proteins 0
Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114342

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Angelika Janaszkiewicz (A)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France.

Ágota Tóth (Á)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France.

Quentin Faucher (Q)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utre-cht University, 3584 CG Utrecht, The Netherlands.

Hélène Arnion (H)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France.

Nicolas Védrenne (N)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France.

Chantal Barin-Le Guellec (C)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France; CHU de Tours, 2 Boulevard Tonnellé, 37044 Tours, France.

Pierre Marquet (P)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France; Department of Pharmacology and Toxicology, CHU Limoges, F-87000 Limoges, France.

Florent Di Meo (F)

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France. Electronic address: florent.di-meo@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH